Hemostasis or haemostasis is a complex process which causes the bleeding process to stop. Most times this includes the changing of blood from a fluid to a solid state. Intact blood vessels are central to moderating blood's tendency to clot.
As open surgery has gradually been replaced by minimally-invasive and image-guided procedures, tissue adhesives are taking the place of sutures and surgical staples.
An international team of hematologists including Guy Young, MD, of Children's Hospital Los Angeles, has found that in patients with hemophilia A with inhibitors, a novel therapy called emicizumab, decreases incidence of bleeding episodes by 87%.
The Stago group announced today that it has completed the acquisition of HemoSonics LLC, a company specialized in the development of innovative Point-of-Care testing solutions based in Charlottesville, VA, with facilities in Durham, NC (USA).
It may be possible to disrupt harmful blood clots in people at risk for heart attack or stroke without increasing their risk of bleeding, according to a new study published in Nature Communications.
Novo Nordisk today announced the availability of HemaGo™ XChange, a web-based portal that allows people with hemophilia to connect their circle of care to their treatment and bleed information, promoting collaboration and discussion regarding the management of their bleeding disorder.
The International Society on Thrombosis and Haemostasis (ISTH), in partnership with John Wiley and Sons, Inc., announces the launch of the Society's new open access journal, Research and Practice in Thrombosis and Haemostasis (RPTH), with its inaugural issue to publish in conjunction with the meeting of the ISTH 2017 Congress in Berlin, Germany, July 8-13.
Qosina is pleased to announce that we have received ISO 13485 Certification, a globally recognized standard that specifies the requirements for a quality management system that can be used by organizations providing medical devices, components and delivery of related services.
Richard Wolf GmbH is presenting its new system solutions for minimally invasive human medicine at the International Trade Fair for Medical Technology – MEDICA 2016, November 14-17, 2016 – at the newly designed exhibition booth under the motto “feel the spirit of excellence”.
Boston Scientific Corporation today announced the launch of the Resolution 360 Clip, a novel technology designed to improve hemostatic clipping by providing physicians controlled rotation designed for more accurate clip placement.
As demand for the widely used blood thinning drug heparin continues to grow, experts worry of possible shortages of the essential medication.
Siemens Healthineers has more than 30 years of central lab hemostasis leadership. Building on to its portfolio, the company announced today FDA 510(k) clearance for a hand-held portable coagulation analyzer.
Roughly one-third of all births in Europe and North America now occur via cesarean section (CS). Following any birth, women are at an increased risk for a venous thromboembolism (VTE), but it's believed that CS leaves women more vulnerable to VTE, blood clots, than vaginal delivery (VD).
Qosina is pleased to announce the addition of eight new barbed check valves to complement their extensive line of stock components. Available in three different configurations, these barbed valves have a low, 0.087 psi cracking pressure.
A specially designed antidote to reverse acute, potentially life-threatening anticoagulant-related bleeding worked quickly, and was well-tolerated according to interim results of the ongoing ANNEXA-4 study.
When in dysfunction, the vascular endothelium -- the tissue that lines the blood vessels throughout our body's entire circulatory system -- plays a big role in the development of many human diseases, including diabetes, stroke, heart disease, viral infections and cancer.
Today, Siemens Healthineers Laboratory Diagnostics business launched the Sysmex CS-2500 System—a mid-volume, fully-automated coagulation analyzer with smartly-designed PSI technology—in major markets including the U.S. Together with Lab Alliance of Central New York, the first U.S. customer to install the high-volume Sysmex CS-5100 System, the company celebrated the availability of its new Sysmex CS Hemostasis System portfolio in the U.S.
LGC Maine Standards is pleased to announce our VALIDATE D-Dimer calibration verification / linearity test kit has received US FDA 510(k) clearance for use on Instrument Laboratory ACL TOP hemostasis test systems.
Increasing oxygen delivery to muscles can help athletes perform better and give them the edge needed to win elite competitions. One of the best ways to increase oxygen supply is through blood manipulation, undergoing a blood transfusion that provides extra red blood cells and boosts oxygen levels.
Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has received CE Mark approval for MANTA, the company's Large Bore Vascular Closure Device.
More than 20 percent of all blood clots in veins occur in cancer patients. These clots, also known as venous thromboembolism (VTE), pose serious threats for cancer patients.